BR9609521A - Fator de crescimento de tecido conectivo - Google Patents
Fator de crescimento de tecido conectivoInfo
- Publication number
- BR9609521A BR9609521A BR9609521A BR9609521A BR9609521A BR 9609521 A BR9609521 A BR 9609521A BR 9609521 A BR9609521 A BR 9609521A BR 9609521 A BR9609521 A BR 9609521A BR 9609521 A BR9609521 A BR 9609521A
- Authority
- BR
- Brazil
- Prior art keywords
- ctgf
- growth factor
- connective tissue
- tissue growth
- provides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0655—Chondrocytes; Cartilage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/459,717 US5770209A (en) | 1991-08-30 | 1995-06-02 | Acceleration of wound healing using connective tissue growth factor |
PCT/US1996/008140 WO1996038172A1 (en) | 1995-06-02 | 1996-05-31 | Connective tissue growth factor |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9609521A true BR9609521A (pt) | 1999-06-15 |
Family
ID=23825885
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9608558-4A BR9608558A (pt) | 1995-06-02 | 1996-05-31 | Processos e usos de fator de crescimento de tecido conjuntivo como um agente de indução |
BR9609521A BR9609521A (pt) | 1995-06-02 | 1996-05-31 | Fator de crescimento de tecido conectivo |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9608558-4A BR9608558A (pt) | 1995-06-02 | 1996-05-31 | Processos e usos de fator de crescimento de tecido conjuntivo como um agente de indução |
Country Status (11)
Country | Link |
---|---|
US (4) | US5770209A (pt) |
EP (2) | EP0831885A4 (pt) |
JP (4) | JPH11507332A (pt) |
CN (2) | CN1195295A (pt) |
AT (1) | ATE464067T1 (pt) |
AU (2) | AU720268B2 (pt) |
BR (2) | BR9608558A (pt) |
CA (2) | CA2222509C (pt) |
DE (1) | DE69638162D1 (pt) |
SG (1) | SG108208A1 (pt) |
WO (2) | WO1996038168A1 (pt) |
Families Citing this family (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5408040A (en) * | 1991-08-30 | 1995-04-18 | University Of South Florida | Connective tissue growth factor(CTGF) |
US7384634B2 (en) | 1991-08-30 | 2008-06-10 | University Of South Florida | Connective tissue growth factor |
US7026299B2 (en) | 1994-07-12 | 2006-04-11 | Human Genome Sciences, Inc. | Connective tissue growth factor-2 |
US6638912B2 (en) | 1995-05-01 | 2003-10-28 | The Regents Of The University Of California | Peptide compositions mimicking TGF-β activity |
AU763649B2 (en) * | 1995-06-02 | 2003-07-31 | University Of South Florida | Connective tissue growth factor |
US7521540B2 (en) * | 1996-03-15 | 2009-04-21 | Munin Corporation | CYR61 compositions and methods |
US6413735B1 (en) | 1996-03-15 | 2002-07-02 | Munin Corporation | Method of screening for a modulator of angiogenesis |
US20090081228A1 (en) * | 1996-03-15 | 2009-03-26 | Munin Corporation | Cyr61 compositions and methods |
US6790606B1 (en) * | 1996-03-15 | 2004-09-14 | Munin Corporation | Extracellular matrix signaling molecules |
ES2246056T3 (es) * | 1996-11-08 | 2006-02-01 | Human Genome Sciences, Inc. | Factor 3 de crecimiento de tejido conjuntivo. |
US20040132987A1 (en) | 1996-11-08 | 2004-07-08 | Human Genome Sciences, Inc. | Connective tissue growth factor-3 |
CA2274122C (en) * | 1996-12-06 | 2004-02-17 | Osiris Therapeutics, Inc. | Improved chondrogenic differentiation of human mesenchymal stem cells |
DE19719652A1 (de) * | 1997-05-09 | 1998-12-03 | Merckle Gmbh | Tissue-Faktor zur Förderung von Wundheilung |
JP2001517093A (ja) * | 1997-06-19 | 2001-10-02 | インサイト・ファーマスーティカルズ・インコーポレイテッド | 成長因子様タンパク質をコードするポリヌクレオチド |
WO1998057976A1 (en) * | 1997-06-19 | 1998-12-23 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
US5876730A (en) * | 1997-08-07 | 1999-03-02 | Childrens Hospital Research Foundation | Heparin-binding growth factor (HBGF) polypeptides |
JP4537507B2 (ja) * | 1997-12-25 | 2010-09-01 | アムジェン インコーポレイテッド | 結合組織増殖因子に対するモノクローナル抗体及びその医薬用途 |
EP1043335A4 (en) | 1997-12-25 | 2005-08-31 | Japan Tobacco Inc | MONOCLONAL ANTIBODY AGAINST CONNECTIVE TISSUE GROWTH FACTOR AND ITS MEDICAL APPLICATIONS |
US20070141181A1 (en) * | 1998-02-13 | 2007-06-21 | Nutramax Laboratories, Inc. | Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
CA2320202C (en) * | 1998-02-13 | 2010-09-14 | Nutramax Laboratories, Inc. | Agents and methods for protection, treatment and repair of connective tissue |
US6451771B1 (en) | 1999-02-12 | 2002-09-17 | Nutramax Laboratories, Inc. | Use of anabolic agents anti-catabolic agents and antioxidant agents for protection treatment and repair of connective tissues in humans and animals |
US6797289B2 (en) * | 1998-02-13 | 2004-09-28 | Nutramax Laboratories, Inc. | Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
CN1326361A (zh) * | 1998-09-08 | 2001-12-12 | 亨利福特保健***公司 | 通过修饰、调节及抑制***生长因子来检查、预防和治疗肾脏疾病的方法 |
US6348329B1 (en) | 1998-11-06 | 2002-02-19 | Fibrogen, Inc. | Nucleic acids encoding rat connective tissue growth factor (CTGF) and methods of use |
US7115390B1 (en) * | 1998-12-14 | 2006-10-03 | Fibrogen, Inc. | Connective tissue growth factor fragments and methods and uses thereof |
US6350472B1 (en) * | 1998-12-14 | 2002-02-26 | Steinbach, Pylant, And Hermann, L.L.C. | Method of treating HIV infection with transdermal gel containing mammalian liver extract |
WO2000035936A1 (en) | 1998-12-14 | 2000-06-22 | University Of Miami | Connective tissue growth factor fragments and methods and uses thereof |
KR100704537B1 (ko) * | 1999-02-01 | 2007-04-09 | 제네틱스 인스티튜트, 엘엘씨 | 관절 연골의 치유 및 회복을 위한 조성물 |
CA2366289A1 (en) * | 1999-03-25 | 2000-09-28 | Radoje T. Drmanac | Solution-based methods and materials for sequence analysis by hybridization |
WO2001015729A1 (en) | 1999-08-27 | 2001-03-08 | Fibrogen, Inc. | Connective tissue growth factor receptor, its agonists and antagonists, and their therapeutic and diagnostic uses |
US20060052328A1 (en) * | 2000-07-11 | 2006-03-09 | Human Genome Sciences, Inc. | Connective tissue growth factor-2 |
CA2412124A1 (en) * | 2000-07-11 | 2002-01-17 | Haodong Li | Connective tissue growth factor-2 |
US6939540B1 (en) | 2000-07-31 | 2005-09-06 | Cornell Research Foundation, Inc. | Method of enhancing bone density |
US6599526B2 (en) * | 2000-08-18 | 2003-07-29 | The University Of North Texas Health Science Center At Fort Worth | Pericardial anti-adhesion patch |
US7125715B2 (en) | 2000-11-22 | 2006-10-24 | Astellas Pharma Inc. | Nucleic acid encoding a polypeptide promoting type II collagen formation and aggrecan production |
AU2002326939A1 (en) * | 2001-09-18 | 2003-04-01 | Fibrogen, Inc. | Methods of assaying connective tissue growth factor |
EP1438067A4 (en) * | 2001-09-24 | 2006-06-14 | Verigen Ag | AUTOLOGICAL GROWTH FACTOR COCKTAIL COMPOSITION, MANUFACTURING METHOD AND USE |
JP4456796B2 (ja) * | 2001-09-27 | 2010-04-28 | 株式会社林原生物化学研究所 | コラーゲン産生増強剤の製造方法とその用途 |
US6965025B2 (en) | 2001-12-10 | 2005-11-15 | Isis Pharmaceuticals, Inc. | Antisense modulation of connective tissue growth factor expression |
MXPA04005628A (es) * | 2001-12-12 | 2004-12-06 | Merck Patent Gmbh | Inhibicion de tristetraprolina para proteger al corazon contra lesiones cardiacas. |
EP1616568A3 (en) | 2002-04-30 | 2006-06-21 | Alcon, Inc | GSK-3 inhibitors and CDK inhibitors as anti-glaucoma agents |
PL378030A1 (pl) * | 2002-04-30 | 2006-02-20 | Alcon, Inc. | Czynniki które regulują, hamują lub modulują działanie i/lub wyrażanie czynnika wzrostowego tkanki łącznej (CTGF), jako wyjątkowe środki do obniżania ciśnienia śródgałkowego i leczenia retinopatii jaskrowej/neuropatii nerwu wzrokowego |
WO2004099372A2 (en) * | 2003-05-01 | 2004-11-18 | University Of Florida | Anti-scarring ribozymes and methods |
US7405274B2 (en) * | 2003-06-04 | 2008-07-29 | Fibrogen, Inc. | Connective tissue growth factor antibodies |
US20050153395A1 (en) * | 2003-09-29 | 2005-07-14 | Children's Hospital Inc. | Unique integrin binding site in connective tissue growth factor (CTGF) |
US8258105B2 (en) * | 2003-10-07 | 2012-09-04 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotides optimized for kidney targeting |
US20050191653A1 (en) * | 2003-11-03 | 2005-09-01 | Freier Susan M. | Modulation of SGLT2 expression |
WO2005077413A1 (en) | 2004-02-11 | 2005-08-25 | Fibrogen, Inc. | Ctgf as target for the therapy of diabetic nephropathy |
CA2565070A1 (en) | 2004-04-28 | 2005-11-24 | Fibrogen, Inc. | Anti-ctgf agents for the treatment of pancreatic cancer |
WO2005120231A1 (en) * | 2004-06-08 | 2005-12-22 | Fibrogen, Inc. | Connective tissue growth factor regulates intracellular signaling pathways |
TWI386225B (zh) | 2004-12-23 | 2013-02-21 | Alcon Inc | 用於治療眼睛病症的結締組織生長因子(CTGF)RNA干擾(RNAi)抑制技術 |
WO2006102333A2 (en) * | 2005-03-21 | 2006-09-28 | Alcon Manufacturing, Ltd. | Ophthalmic use of agents which inhibit connective tissue growth factor binding and signalling via the trka/p75ntr receptor complex |
MX2007013834A (es) | 2005-05-05 | 2008-02-05 | Fibrogen Inc | Terapias de enfermedades vasculares. |
US20110244006A1 (en) * | 2007-11-29 | 2011-10-06 | The Trustees Of Columbia University In The City Of New York | Microsphere skin treatment |
US20100331249A1 (en) * | 2008-07-23 | 2010-12-30 | National Taiwan University | Pharmaceutical composition for inhibiting peritoneal dissemination |
EP3081648A1 (en) | 2008-08-25 | 2016-10-19 | Excaliard Pharmaceuticals, Inc. | Antisense oligonucleotides directed against connective tissue growth factor and uses thereof |
US8946172B2 (en) | 2008-08-25 | 2015-02-03 | Excaliard Pharmaceuticals, Inc. | Method for reducing scarring during wound healing using antisense compounds directed to CTGF |
EP2340310B1 (en) * | 2008-09-22 | 2015-06-03 | RXi Pharmaceuticals Corporation | Reduced size self-delivering rnai compounds |
EP2221387A1 (en) * | 2009-02-19 | 2010-08-25 | Université de la Méditerranée | Fibrosis susceptibility gene and uses thereof |
JP5166360B2 (ja) * | 2009-06-23 | 2013-03-21 | 株式会社島津製作所 | マイクロ反応装置を用いた細胞運動評価方法 |
CN102666587A (zh) | 2009-07-02 | 2012-09-12 | 菲布罗根有限公司 | 用于治疗肌营养不良的方法 |
WO2011056234A1 (en) | 2009-11-06 | 2011-05-12 | Fibrogen, Inc. | Treatment for radiation-induced disorders |
EP3578183B1 (en) | 2010-03-24 | 2021-09-08 | Phio Pharmaceuticals Corp. | Rna interference in ocular indications |
EP2550002B1 (en) | 2010-03-24 | 2019-05-08 | Phio Pharmaceuticals Corp. | Rna interference in dermal and fibrotic indications |
KR101249041B1 (ko) | 2010-04-28 | 2013-03-29 | 포항공과대학교 산학협력단 | 결합조직 성장인자를 이용한 약학적 조성물 |
WO2012061811A2 (en) | 2010-11-05 | 2012-05-10 | Fibrogen, Inc. | Treatment method for lung remodeling diseases |
US9102721B2 (en) | 2011-01-21 | 2015-08-11 | Fibrogen, Inc. | Therapeutic method |
JP6177692B2 (ja) | 2011-02-02 | 2017-08-09 | エクスカリアード・ファーマシューティカルズ,インク | 結合組織増殖因子(ctgf)をターゲティングするアンチセンス化合物を用いた、ケロイドまたは肥厚性瘢痕の治療法 |
US10150989B2 (en) | 2011-08-05 | 2018-12-11 | Universite D'aix Marseille | Fibrosis susceptibility IL22RA2 gene and uses thereof |
WO2013165590A1 (en) | 2012-05-03 | 2013-11-07 | Fibrogen, Inc. | Methods for treating idiopathic pulmonary fibrosis |
US9631013B2 (en) | 2014-01-28 | 2017-04-25 | Fibrogen, Inc. | Therapeutic method for pancreatic cancer |
US20210395690A1 (en) * | 2018-11-08 | 2021-12-23 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Anchorage-independent cells and use thereof |
US20220324953A1 (en) | 2019-06-04 | 2022-10-13 | Jiangsu Hengrui Medicine Co., Ltd. | Anti-connective tissue growth factor antibody and application thereof |
WO2021067694A1 (en) * | 2019-10-03 | 2021-04-08 | CyPhi LLC | Method of connective tissue restoration |
JP2023129339A (ja) * | 2022-03-02 | 2023-09-14 | イーク ビョルン | 結合組織損傷の治療 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1989A (en) | 1841-02-20 | Stump-extractor | ||
US5356630A (en) * | 1989-02-22 | 1994-10-18 | Massachusetts Institute Of Technology | Delivery system for controlled release of bioactive factors |
US5149691A (en) * | 1991-03-12 | 1992-09-22 | Creative Biomolecules, Inc. | Issue repair and regeneration through the use of platelet derived growth factor (pdgf) in combination with dexamethasone |
FR2678283A1 (fr) * | 1991-06-25 | 1992-12-31 | Centre Nat Rech Scient | Sequences de nucleotides, sequences d'acides amines correspondantes, et leurs applications biologiques. |
US5408040A (en) * | 1991-08-30 | 1995-04-18 | University Of South Florida | Connective tissue growth factor(CTGF) |
IL105529A0 (en) * | 1992-05-01 | 1993-08-18 | Amgen Inc | Collagen-containing sponges as drug delivery for proteins |
-
1995
- 1995-06-02 US US08/459,717 patent/US5770209A/en not_active Expired - Lifetime
-
1996
- 1996-05-31 DE DE69638162T patent/DE69638162D1/de not_active Expired - Lifetime
- 1996-05-31 CA CA2222509A patent/CA2222509C/en not_active Expired - Lifetime
- 1996-05-31 CN CN96195711A patent/CN1195295A/zh active Pending
- 1996-05-31 CA CA002222609A patent/CA2222609A1/en not_active Abandoned
- 1996-05-31 EP EP96920597A patent/EP0831885A4/en not_active Withdrawn
- 1996-05-31 BR BR9608558-4A patent/BR9608558A/pt not_active Application Discontinuation
- 1996-05-31 AU AU59582/96A patent/AU720268B2/en not_active Expired
- 1996-05-31 AT AT96916841T patent/ATE464067T1/de not_active IP Right Cessation
- 1996-05-31 AU AU58855/96A patent/AU722919B2/en not_active Ceased
- 1996-05-31 JP JP8536688A patent/JPH11507332A/ja not_active Withdrawn
- 1996-05-31 WO PCT/US1996/008210 patent/WO1996038168A1/en not_active Application Discontinuation
- 1996-05-31 JP JP8536723A patent/JPH11506449A/ja active Pending
- 1996-05-31 EP EP96916841A patent/EP0831903B1/en not_active Expired - Lifetime
- 1996-05-31 CN CN96195767A patent/CN1191491A/zh active Pending
- 1996-05-31 WO PCT/US1996/008140 patent/WO1996038172A1/en active Application Filing
- 1996-05-31 SG SG9806251A patent/SG108208A1/en unknown
- 1996-05-31 BR BR9609521A patent/BR9609521A/pt not_active Application Discontinuation
-
1998
- 1998-03-30 US US09/056,704 patent/US6232064B1/en not_active Expired - Fee Related
- 1998-04-02 US US09/054,274 patent/US6150101A/en not_active Expired - Fee Related
- 1998-04-02 US US09/054,368 patent/US6069006A/en not_active Expired - Fee Related
-
2003
- 2003-09-11 JP JP2003320335A patent/JP2004132974A/ja active Pending
-
2006
- 2006-10-04 JP JP2006273122A patent/JP2007051150A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2007051150A (ja) | 2007-03-01 |
AU5958296A (en) | 1996-12-18 |
AU5885596A (en) | 1996-12-18 |
US6069006A (en) | 2000-05-30 |
JPH11507332A (ja) | 1999-06-29 |
CN1191491A (zh) | 1998-08-26 |
BR9608558A (pt) | 1999-11-30 |
DE69638162D1 (de) | 2010-05-27 |
CA2222509A1 (en) | 1996-12-05 |
CA2222609A1 (en) | 1996-12-05 |
US6232064B1 (en) | 2001-05-15 |
SG108208A1 (en) | 2005-01-28 |
CA2222509C (en) | 2012-12-04 |
ATE464067T1 (de) | 2010-04-15 |
JP2004132974A (ja) | 2004-04-30 |
US5770209A (en) | 1998-06-23 |
AU720268B2 (en) | 2000-05-25 |
EP0831903A4 (en) | 2001-02-28 |
WO1996038168A1 (en) | 1996-12-05 |
CN1195295A (zh) | 1998-10-07 |
EP0831885A4 (en) | 2000-11-29 |
MX9709294A (es) | 1998-08-30 |
AU722919B2 (en) | 2000-08-17 |
EP0831903A1 (en) | 1998-04-01 |
EP0831885A1 (en) | 1998-04-01 |
EP0831903B1 (en) | 2010-04-14 |
US6150101A (en) | 2000-11-21 |
WO1996038172A1 (en) | 1996-12-05 |
JPH11506449A (ja) | 1999-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9609521A (pt) | Fator de crescimento de tecido conectivo | |
AU2001294541A1 (en) | Mammalian genes; related reagents and methods | |
DE69836630D1 (de) | Menschliche toll-ähnliche rezeptorproteine, zugehörige reagenzien und verfahren | |
PT100781A (pt) | Sequencias de dna codificadoras de proteinas de superficie externa, proteinas contendo as referidas sequencias, obtidas a partir de borrelia burgdorferi, e vacinas contendo as referidas proteinas | |
FI961251A (fi) | Ihmisten metabotrooppiset glutamaattireseptorialatyypit(HMR4, HMR6, HMR7)ja niihin liittyvät DNA-yhdisteet | |
NZ323795A (en) | Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides | |
BR9810907A (pt) | Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico | |
AU1342888A (en) | Molecules comprising at least one peptidic sequence carrying one or a plurality of epitopes characterizing a protein produced by P.Falciparum in hepatocytes and compositions containing them | |
SE9500023D0 (sv) | Method of detecting cancer | |
EP1908837A3 (en) | Human receptor proteins, related reagents and methods | |
NO20030495L (no) | Peptider som presenteres av celler | |
WO2000042188A3 (en) | Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses | |
WO1999046379A3 (en) | Human receptor proteins; related reagents and methods | |
BR9713450A (pt) | Quimiocinas de mamìfero | |
WO1998032858A3 (en) | Mammalian chemokines; receptors; reagents; uses | |
AU2818095A (en) | Colon specific gene and protein | |
EP0960937A4 (en) | NEW SEMAPHORIN GENE: SEMAPHORIN Y | |
WO1998031810A3 (en) | Mammalian chemokines; receptors; reagents; uses | |
DE69734199D1 (de) | Menschliches netrin-1 | |
EP0780472A3 (en) | Stress proteins | |
AU2347501A (en) | Trp-protein-related mtr1 protein and dna sequence coding therefor | |
WO1998041538A3 (en) | Novel human cytokine/steroid receptor protein | |
WO1999019480A3 (en) | Human receptor proteins; related reagents and methods | |
WO2000034335A3 (en) | 'death domain' containing receptors | |
WO1998042868A3 (en) | Screening method for proline-rich proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law |